Solcoseryl

DB15794InvestigationalOrganism Based Therapies

Solcoseryl is a component of calf blood indicated to improve healing of the skin, mouth, or cornea.

Resolves to

Targets
P14780MMP9P08253MMP2

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
13Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
8Marketed productsAcross 3 countries and 2 labellers
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Solcoseryl, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In